Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Total Debt (2018 - 2025)

Rockwell Medical's Total Debt history spans 10 years, with the latest figure at $8.8 million for Q4 2025.

  • For Q4 2025, Total Debt fell 18.6% year-over-year to $8.8 million; the TTM value through Dec 2025 reached $8.8 million, down 18.6%, while the annual FY2025 figure was $8.8 million, 18.6% down from the prior year.
  • Total Debt reached $8.8 million in Q4 2025 per RMTI's latest filing, down from $10.5 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $21.2 million in Q3 2021 to a low of $8.8 million in Q4 2025.
  • Average Total Debt over 5 years is $13.2 million, with a median of $10.8 million recorded in 2024.
  • Peak YoY movement for Total Debt: crashed 55.34% in 2022, then rose 18.91% in 2024.
  • A 5-year view of Total Debt shows it stood at $20.6 million in 2021, then plummeted by 55.34% to $9.2 million in 2022, then grew by 17.49% to $10.8 million in 2023, then rose by 0.46% to $10.8 million in 2024, then decreased by 18.6% to $8.8 million in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Total Debt are $8.8 million (Q4 2025), $10.5 million (Q3 2025), and $11.1 million (Q2 2025).